Overexpression of laminin-5 γ2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: Association with expression of cyclooxygenase 2, epidermal growth factor, and human epidermal growth factor 2

Human Pathology

Volumn 36, Issue 5, 2005, Pages 522-530

  Kiyoshima, Keijiro ^a   Oda, Yoshinao ^a   Kinukawa, Naoko ^a   Naito, Seiji ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

COX 2; erbB; Laminin 5; Urinary bladder; Urothelial carcinoma

Indexed keywords

BIOLOGICAL MARKER; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KALININ;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; BLADDER CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TRANSURETHRAL RESECTION; URINARY TRACT CARCINOMA; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES; UROTHELIUM;

EID: 20144386005     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2005.02.013     Document Type: Article

References (43)

1. Research Group for Population-based Cancer Registries in Japan Cancer incidence and incidence rates in Japan in 1998: estimates based on data from 12 population-based cancer registries Jpn J Clin Oncol 33 2003 241 245
2. D.M. Parkin, F. Bray, and J. Ferlay Estimating the world cancer burden: GLOBOCAN 2000 Int J Cancer 94 2001 153 156
3. J.N. Eble G. Sauter J.I. Epstein World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs 2004 IARC Press Lyon 89 120
4. E.M. Messing Urothelial tumors of the urinary tract P.C. Walsh A.B. Retik E.D. Vaughan A.J. Wein Campbell's urology 8th ed. 2002 Saunders Philadelphia 2743
5. L.H. Sobin, and C.H. Wittekind TNM classification of malignant tumors 5th ed. 1997 Wiley-Liss New York 187 190
6. R. Timpl Structure and biological activity of basement membrane proteins Eur J Biochem 180 1989 487 502
7. H. Colognato, and P.D. Yurchenco Form and function: the laminin family of heterodimers Dev Dyn 218 2000 213 234
8. Y. Moriya, T. Niki, and T. Yamada Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size: an immunohistochemical analysis of 102 cases Cancer 91 2001 1129 1141
9. G. Giannelli, J. Falk-Marzillier, and O. Schiraldi Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5 Science 277 1997 225 228
10. N. Koshikawa, G. Giannelli, and V. Cirulli Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5 J Cell Biol 148 2000 615 624
11. C. Pyke, S. Salo, and E. Ralfkiær Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas Cancer Res 55 1995 4132 4139
12. Y. Soini, M. Määttä, and S. Salo Expression of the laminin gamma 2 chain in pancreatic adenocarcinoma J Pathol 180 1996 290 294
13. Y. Ono, Y. Nakanishi, and Y. Ino Clinicopathologic significance of laminin-5 gamma2 chain expression in squamous cell carcinoma of the tongue: immunohistochemical analysis of 67 lesions Cancer 85 1999 2315 2321
14. N. Koshikawa, K. Moriyama, and H. Takamura Overexpression of laminin gamma2 chain monomer in ivading gastric carcinoma cells Cancer Res 59 1999 5596 5601
15. W. Hindermann, A. Berndt, and K.M. Haas Immunohistochemical demonstration of the gamma2 chain of laminin-5 in urinary bladder urothelial carcinoma. Impact for diagnosis and prognosis Cancer Detec Prev 27 2003 109 115
16. B.S. Reddy, C.V. Rao, and K. Seibert Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis Cancer Res 56 1996 4566 4569
17. A. Ristimäki, N. Honkanen, and H. Jänkälä Expression of cyclooxygenase-2 in human gastric carcinoma Cancer Res 57 1997 1276 1280
18. H. Wolff, K. Saukkonen, and S. Anttila Expression of cyclooxygenase-2 in human lung carcinoma Cancer Res 58 1998 4997 5001
19. O.N. Tucker, A.J. Dannenberg, and E.K. Yang Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer Cancer Res 59 1999 987 990
20. T. Shirahama, J. Arima, and S. Akiba Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder Cancer 92 2001 188 193
21. S.L. Kim, S.M. Kwon, and Y.S. Kim Association of cyclooxygenase-2 expression with prognosis of stage T1 grade 3 bladder cancer Urology 60 2002 816 821
22. S.F. Shariat, K. Matsumoto, and J. Kim Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder J Urol 170 2003 985 989
23. T. Niki, T. Kohno, and S. Iba Frequent co-localization of COX-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinoma Am J Pathol 160 2002 1129 1141
24. R.J. Coffey, C.J. Hawkey, and L. Damstrup Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells Proc Natl Acad Sci U S A 94 1997 657 662
25. J.R. Mestre, G. Chan, and F. Zhang Inhibition of cyclooxygenase-2 expression. An approach to preventing head and neck cancer Ann N Y Acad Sci 889 1999 62 71
26. K. Kiguchi, S. Carbajal, and K. Chan Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma Cancer Res 61 2001 6971 6976
27. K. Endo, B.I. Yoon, and C. Pairojkul ErbB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions Hepatology 36 2002 439 450
28. H. Mizushima, Y. Miyagi, and Y. Kikkawa Differential expression of laminin-5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors J Biochem 120 1996 1196 1202
29. Y. Ono, Y. Nakanishi, and M. Gotoh Epidermal growth factor gene amplification is correlated with laminin-5 gamma2 chain expression in oral squamous cell carcinoma cell lines Cancer Lett 175 2002 197 204
30. V. Rusch, D. Klimstra, and E. Venkatraman Overexpression of the epidermal growth factor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression Clin Cancer Res 3 1997 515 522
31. R. Gandour-Edwards, P.N. Lara Jr., and A.K. Folkins Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma? Cancer 95 2002 1009 1015
32. I. Sordat, F.T. Bosman, and G. Dorta Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia J Pathol 185 1998 44 52
33. T. Hirosaki, H. Mizushima, and Y. Tsubota Structural requirement of carboxyl-terminal globular domains of laminin alpha 3 chain for promotion of rapid cell adhesion and migration by laminin-5 J Biol Chem 275 2000 22495 22502
34. R. Ohno, K. Yoshinaga, and T. Fujita Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma Cancer 91 2001 1876 1881
35. H. Murata, S. Kawano, and S. Tsuji Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma Am J Gastroenterol 94 1999 451 455
36. H. Achiwa, Y. Yatabe, and T. Hida Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas Clin Cancer Res 5 1999 1001 1005
37. F.R. Khuri, H. Wu, and J.J. Lee Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer Clin Cancer Res 7 2001 861 867
38. G. Ferrandina, F.O. Ranelletti, and L. Lauriola Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and HER-2/neu expression in ovarian cancer Gynecol Oncol 85 2002 305 310
39. E.M. Messing Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors Semin Surg Oncol 8 1992 285 292
40. D.E. Neal, and K. Mellon Epidermal growth factor receptor and bladder cancer: a review Urol Int 48 1992 365 371
41. V.B. Thogersen, P.E. Jorgensen, and B.S. Sorensen Expression of transforming growth factor alpha and epidermal growth factor receptor in human bladder cancer Scand J Clin Lab Invest 59 1992 267 277
42. R.E. Jimenez, M. Hussain, and F.J. Bianco Jr. HER-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors Clin Cancer Res 7 2001 2440 2447
43. A. Onn, A.M. Correa, and M. Gilcrease Synchronous overexpression of epidermal growth factor receptor and HER-2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer Clin Cancer Res 10 2004 136 143